Pricing

Log inSign up

Aligos Therapeutics

0 followers

‌

Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

51-200

Links

Org chart

Lawrence M. Blatt
Chairman & CEO

Lawrence M. Blatt

Collapse
Lesley Ann Calhoun
EVP & CFO
Lucinda Y. Quan
EVP, Chief Business Officer & General Counsel
Julian A. Symons
EVP & Chief Scientific Officer
Dave Smith
Executive Vice President
Tse-I Lin
VP, Early Compound Development & Belgian Site Head
Kristina Engeseth
VP & Head, People & Culture
Dinah Misner
Vice President
Hardean E. Achneck
Chief Medical Officer
Kha le
Executive Director

Teams

+12

Research and Development Scientists

15 members

+3

Leadership Team

6 members

+4

Operations and Management

7 members

Offices

Similar companies

REVOLUTION Medicines

5 followers

Immunovant

5 followers

Summit Therapeutics

5 followers

Dyne Therapeutics

3 followers

Viridian Therapeutics

2 followers

Vaxart

2 followers

Gamida Cell

2 followers

Vividion Therapeutics

1 follower

Entrada Therapeutics

1 follower

Mersana Therapeutics

1 follower

Century Therapeutics

1 follower

Explore companies